<DOC>
	<DOCNO>NCT01200693</DOCNO>
	<brief_summary>BACKGROUND : Bifurcated lesion challenge subset percutaneous coronary intervention ( PCI ) . The selection type drug-eluting stent ( DES ) technique stent implantation clarify . The side-branch ( SB ) emerge critical point , account third significant restenosis DES era . A series data support adoption conservative strategy : stenting main vessel ( MV ) reserve conservative approach SB . Yet , clinical relevance term inducible ischemia sub-optimal angiographic result clarify . AIMS OF THE STUDY : The aim present study : 1. compare prospective study acute 3D angiographic result late clinical outcome Sirolimus-eluting ( SES ) vs Everolimus-eluting ( EES ) v Zotarolimus elute stent ( ZES ) obtain use provisional TAP-stenting technique . 2. prospectively assess clinical relevance ( inducible ischemia ) suboptimal angiographic result SB stenting . METHODS TO BE APPLIED : 75 consecutive patient bifurcate lesion undergo PCI provisional T-and-small-protruding ( TAP ) technique ZES implantation enrol . Procedural post-PCI detail prospectively record . The subgroup patient complete revascularization achieve enter systematic assessment inducible ischemia early late exercise test . Off line 3D quantitative coronary angiography ( QCA ) assessment perform use divide study population 2 group accord SB residual stenosis : - Group O ( optimal SB angiographic result ) : post-PCI SB area stenosis &lt; 50 % - Group S ( sub-optimal SB angiographic result ) : post-PCI SB area stenosis &gt; 50 % . For comparison among SES EES , data obtain randomized trial SEA-SIDE ( NCT00697372 ) . PRIMARY STUDY END-POINTS . 1 . COMPARISON BETWEEN ZES , SES AND EES : SB acute angiographic result ; SB trouble ; target bifurcation failure . 2 . SB-RELATED ISCHAEMIA Group O v Group S patient complete revascularization : inducible ischemia early exercise test occurrence early spontaneous ischemia relate SB .</brief_summary>
	<brief_title>Z-SEA-SIDE : Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment Bifurcated Lesions Clinical SIgnificance Residual siDE-branch Stenosis</brief_title>
	<detailed_description>Bifurcated lesion challenge target lesion percutaneous coronary intervention ( PCI ) may specifically benefit usage drug-eluting stent ( DES ) . However , selection type DES technique DES implantation clarify . In spite technique adopt , side-branch ( SB ) emerge critical point , account third significant restenosis DES era . A series data support adoption conservative strategy : stenting main vessel ( MV ) reserve conservative approach SB associate bad outcome compare complex stenting strategy . Yet , clinical relevance term inducible ischemia sub-optimal angiographic result clarify . AIMS OF THE STUDY : The aim present study : 1. compare prospective study acute 3D angiographic result ( measure impact stent design ) late clinical outcome Sirolimus-eluting ( SES ) vs Everolimus-eluting ( EES ) vs Zotarolimus-eluting stent ( ZES ) obtain use provisional T-and-small-protruding ( TAP ) approach treat bifurcate lesion . 2. prospectively assess clinical relevance ( term inducible ischemia ) suboptimal angiographic result SB bifurcate lesion treat stenting . METHODS TO BE APPLIED : 75 consecutive patient bifurcate lesion undergo PCI provisional TAP-stenting technique ZES implantation enrol . Procedural detail , post-PCI cardiac enzyme release , clinical outcome 1 year prospectively record . After procedure , subgroup patient complete revascularization achieve ( untreated stenosis &gt; 50 % vessel , residual stenosis &gt; 50 % treated vessel ) , enter systematic assessment inducible ischemia early ( &lt; 8 day ) late ( 6-month ) exercise test . Off line 3D quantitative coronary angiography ( QCA ) assessment perform use divide study population 2 group accord SB residual stenosis : Group O ( optimal SB angiographic result ) : post-PCI SB area stenosis &lt; 50 % Group S ( sub-optimal SB angiographic result ) : post-PCI SB area stenosis &gt; 50 % . For comparison among SES EES , data obtain randomized trial SEA-SIDE ( NCT00697372 ) . PRIMARY STUDY END-POINTS . 1 . COMPARISON BETWEEN ZES , SES AND EES : - `` SB acute angiographic result '' : comparison 3DQCA-estimated MLD MLA SB . - `` SB trouble '' : composite : 1. occurrence SB TIMI flow &lt; 3 MV stenting throughout procedure ; 2. need guidewire ( ) different BMW re-wire SB MV stenting ; 3. failure re-wire SB MV stenting ; 4. failure dilate SB MV stenting SB re-wiring . - target bifurcation failure ( TBF ) define target bifurcation-related major adverse coronary event ( MACE ) target bifurcation angiographic failure . 2 . SB-RELATED ISCHAEMIA Group O v Group S patient complete revascularization : inducible ischemia ( diagnostic ST-segment change ) early ( &lt; 8 day ) exercise test occurrence early ( &lt; 12 week ) spontaneous ischemia relate SB ( ischemic episode require unplanned coronary angiography documentation main vessel patency ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>de novo bifurcate lesion lesion &gt; 50 % locate major bifurcation point TIMI &gt; 2 main vessel side branch main vessel visual diameter &gt; 2.5 mm side branch visual diameter &gt; 2.0 mm &gt; 18 year age sign informed consent enter study know hypersensitivity Sirolimus , Everolimus , cobalt , chromium , nickel , tungsten acrylic fluoropolymers contraindication double antiplatelet therapy acute ( within 48 hour ) STelevation acute myocardial infarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
	<keyword>Drug-Eluting Stents</keyword>
</DOC>